How much funding has Aetion raised?

Aetion has raised $203.2M in total funding, most recently a Series C round.

Who are Aetion's investors?

Aetion's investors include Flare Capital Partners, Lakestar, Datavant, Warburg Pincus, JJDC, Amgen Business Development.

Where is Aetion headquartered?

Aetion is headquartered in New York, New York, United States.

What industry is Aetion in?

Aetion operates in Healthcare, SaaS.

Aetion

Acquired

Real-World Evidence Solutions | RWE Analytics

New York, United States · Founded 2013 · $203.2M raised

Healthcare

SaaS

Headquarters: New York, New York
Employees: 201–500
Founded: 2013
Business Model: B2B

Website: aetion.com
Total Funding: $203.2M
Last Round: $110.0M Series CMay 2021
Rounds: 3

About

Aetion is a healthcare technology company providing decision-grade real-world evidence software to biopharmaceutical manufacturers, payers, and regulatory agencies. Its platform includes Discover, Activate, Substantiate, and Generate products for RWE analysis. Aetion was acquired by Datavant in July 2025.

Summary

Aetion is a Healthcare company based in New York, United States, founded in 2013. It has raised $203.2M in total across 3 rounds, most recently a $110.0M Series C round in May 2021. Investors include Flare Capital Partners, Lakestar and Datavant.

LinkedIn X (Twitter)